Lin Vikner, MD
Obstetrics & Gynecology · Paramus, NJNPI 1053310151
Payments from drug & device makers
Across 148 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celularity Inc.$900
- Mayne Pharma Commercial LLC$401
- Astellas Pharma US Inc$345
- AbbVie$204
- Exeltis, USA Inc.$151
- Amgen$134
- plus $923 from 26 others
What the payments were for
- Speaking & faculty fees$90029%
- Food & beverage$2,05167%
- Education$1074%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celularity Inc. | 3 | $900 |
| Mayne Pharma Commercial LLC | 40 | $401 |
| Astellas Pharma US Inc | 16 | $345 |
| AbbVie | 15 | $204 |
| Exeltis, USA Inc. | 10 | $151 |
| Amgen | 9 | $134 |
| Avion Pharmaceuticals | 8 | $108 |
| Evofem Biosciences, Inc. | 7 | $106 |
| Myovant Sciences Inc. | 5 | $81 |
| Pfizer | 4 | $68 |
| BD | 1 | $54 |
| Roche Diagnostics Corporation | 3 | $47 |
| Hologic Sales And Service, LLC | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $33 |
| Sage Therapeutics, LLC | 2 | $31 |
| Organon | 1 | $31 |
| Myriad Women's Health, Inc. | 1 | $30 |
| Agile Therapeutics, Inc. | 2 | $30 |
| Mimedx Group, Inc. | 1 | $30 |
| Therapeuticsmd, Inc. | 2 | $30 |
| Scynexis, Inc. | 2 | $29 |
| Coopersurgical, Inc. | 2 | $27 |
| Dysis Medical, Inc. | 1 | $18 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Mycovia Pharmaceuticals, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Channel Medsystems, Inc. | 1 | $15 |
| Bayer | 1 | $14 |
| Mission Pharmacal Company | 1 | $14 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Duchesnay USA Incorporated | 1 | $14 |
| Vertical Pharmaceuticals, LLC | 1 | $13 |
How this compares
$3,058 in reported general payments places this provider in the 85th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $79 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Paramus
- Cindy ParnesParamus$32K
- Craig WienerParamus$13K
- Khashayar ShakibaParamus$9K
- Jennifer AshtonEnglewood$1.5M
- Gregory HirschMorristown$1.3M
- Steven SussmanLawrenceville$623K
- Geoffrey BowersVoorhees$228K
- Neha DeshpandePlainsboro$206K
- Justin ChuraSwedesboro$193K
- Paula JasionowskiVoorhees$193K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.